| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.451 | 0.006 | 0.515 | NOS3 expression enhancer | 0.515 0.005 DBMET02579 0.435 0.007 DBMET02580 | DBMET02579 | |
| 0.424 | 0.125 | 0.677 | Antiinflammatory | 0.677 0.035 DBMET02579 0.313 0.204 DBMET02580 | DBMET02579 | |
| 0.37 | 0.072 | 0.37 | Toll-Like receptor 7 agonist | 0.327 0.094 DBMET02580 | ||
| 0.368 | 0.074 | 0.368 | Toll-Like receptor agonist | 0.325 0.096 DBMET02580 | ||
| 0.294 | 0.013 | 0.294 | Protein kinase (CK1) delta inhibitor | 0.18 0.036 DBMET02579 0.193 0.031 DBMET02580 | ||
| 0.225 | 0.033 | 0.225 | Protein kinase (CK1) inhibitor | 0.11 0.1 DBMET02579 0.147 0.07 DBMET02580 | ||
| 0.249 | 0.083 | 0.249 | Cardiotonic | 0.176 0.144 DBMET02580 | ||
| 0.27 | 0.109 | 0.306 | Angiogenesis inhibitor | 0.306 0.089 DBMET02579 0.255 0.119 DBMET02580 | DBMET02579 | |
| 0.172 | 0.028 | 0.172 | Proto-oncogene tyrosine-protein kinase Kit inhibitor | 0.088 0.065 DBMET02579 0.111 0.049 DBMET02580 | ||
| 0.174 | 0.033 | 0.266 | Topoisomerase I inhibitor | 0.266 0.014 DBMET02579 0.168 0.035 DBMET02580 | DBMET02579 | |
| 0.157 | 0.018 | 0.157 | Raf kinase inhibitor | 0.087 0.04 DBMET02580 | ||
| 0.162 | 0.025 | 0.162 | Protein kinase (Mos, Mil/Raf, MEKK, RIPK, TESK, LIMK, IRAK, ILK, Activin/TGF-beta) inhibitor | 0.098 0.055 DBMET02580 | ||
| 0.238 | 0.119 | 0.238 | Ca(v)3.3 blocker | 0.211 0.169 DBMET02579 0.215 0.16 DBMET02580 | ||
| 0.179 | 0.061 | 0.179 | Protein kinase (CK1) gamma 3 inhibitor | 0.146 0.094 DBMET02579 0.154 0.085 DBMET02580 | ||
| 0.12 | 0.019 | 0.12 | Raf kinase B inhibitor | 0.059 0.042 DBMET02580 | ||
| 0.171 | 0.088 | 0.187 | P-glycoprotein inhibitor | 0.187 0.073 DBMET02580 | DBMET02580 | |
| 0.253 | 0.18 | 0.253 | Analgesic | |||
| 0.168 | 0.12 | 0.197 | Hypolipemic | 0.197 0.097 DBMET02580 | DBMET02580 | |
| 0.056 | 0.009 | 0.056 | Purinergic P2X3 antagonist | |||
| 0.105 | 0.06 | 0.105 | Nav1.1 sodium channel blocker | 0.093 0.075 DBMET02580 | ||
| 0.239 | 0.225 | 0.24 | Cyclophilin D inhibitor | 0.24 0.225 DBMET02580 | DBMET02580 | |
| 0.112 | 0.102 | 0.273 | Protein kinase stimulant | 0.273 0.021 DBMET02579 0.125 0.087 DBMET02580 | DBMET02579 | |
| 0.111 | 0.101 | 0.111 | Protein kinase (CK1) gamma inhibitor | |||
| 0.053 | 0.049 | 0.054 | Acetyl-CoA transferase 2 inhibitor | 0.054 0.046 DBMET02579 0.053 0.05 DBMET02580 | DBMET02579 | |
| 0.117 | 0.12 | 0.204 | Hemostatic | 0.204 0.031 DBMET02579 0.125 0.104 DBMET02580 | DBMET02579 | |
| 0.128 | 0.145 | 0.15 | Lipocortins synthesis antagonist | 0.15 0.105 DBMET02580 | DBMET02580 | |
| 0.008 | 0.061 | 0.022 | Prostaglandin D2 antagonist | 0.022 0.017 DBMET02580 | DBMET02580 | |
| 0.07 | 0.169 | 0.091 | Hedgehog signaling inhibitor | 0.091 0.082 DBMET02579 | DBMET02579 | |
| 0.018 | 0.135 | 0.068 | Prostaglandin antagonist | 0.068 0.027 DBMET02580 | DBMET02580 | |
| 0.018 | 0.201 | 0.04 | Antibiotic Aminoglycoside-like | 0.04 0.021 DBMET02579 | DBMET02579 | |
| 0.005 | 0.233 | 0.041 | Diacylglycerol O-acyltransferase 1 inhibitor | 0.041 0.012 DBMET02580 | DBMET02580 | |
| 0.057 | 0.328 | 0.133 | Nitric oxide antagonist | 0.133 0.114 DBMET02579 | DBMET02579 | |
| 0.12 | 0.395 | 0.252 | Interleukin 2 agonist | 0.252 0.116 DBMET02579 | DBMET02579 | |
| 0.062 | 0.337 | 0.148 | Hepatoprotectant | 0.148 0.112 DBMET02579 | DBMET02579 | |
| 0.042 | 0.335 | 0.106 | Transcription factor NF kappa B stimulant | 0.106 0.033 DBMET02579 | DBMET02579 | |
| 0.01 | 0.47 | 0.048 | Protein 50S ribosomal subunit inhibitor | 0.048 0.042 DBMET02579 | DBMET02579 | |
| 0.022 | 0.496 | 0.131 | Beta amyloid protein antagonist | 0.131 0.056 DBMET02579 | DBMET02579 | |
| 0.005 | 0.682 | 0.119 | EphA2 antagonist | 0.119 0.055 DBMET02579 | DBMET02579 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |